Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Observation Gait Assessments in subjects with neurological disorders: A Systematic Review.
Opportunistic DNA Recombination with Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.
Regulation of human glia by multiple sclerosis disease modifying therapies.
Female sex steroids and glia cells: Impact on multiple sclerosis lesion formation and fine tuning of the local neurodegenerative cellular network.
Diffuse Granulomatous Inflammation Associated With Long-term Interferon-β Therapy.
Pain Affects Depression Through Anxiety, Fatigue, and Sleep in Multiple Sclerosis.
Can the irradiated brain be salvaged by oligodendrocyte precursor transplantation?
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis.
LC-MS/MS identification of the one-carbon cycle metabolites in human plasma.
Clinical significance of atrophy and white matter mean diffusivity within the thalamus of multiple sclerosis patients.
Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course.
Longitudinal Change in Physical Activity and Its Correlates in Relapsing-Remitting Multiple Sclerosis.
Functions of NOD-Like Receptors in Human Diseases.
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial.
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Efficacy and safety of laquinimod in multiple sclerosis: current status.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Long-term remission of CIDP after pulsed dexamethasone or short-term prednisolone treatment.
TNF-α-mediated anxiety in a mouse model of multiple sclerosis.
Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays.
Pages
« first
‹ previous
…
421
422
423
424
425
426
427
428
429
…
next ›
last »